- Q3
Net Sales of$135.7 Million - Q3 Gross Margin of 26.2%; Non-GAAP Gross Margin of 26.1%
- Q3 EPS of
$0.08 /Share; Q3 Adjusted EPS of$0.08 /Share
Financial Highlights
Net sales were
$135.7 million , an increase of$19.8 million , or 17.1%, from the comparable quarter last year.Gross margin was 26.2% compared with 24.1% in the comparable quarter last year.
Net income was
$3.8 million , or$0.08 per diluted share, compared with$2.1 million , or$0.05 per diluted share, for the comparable quarter last year.Non-GAAP net income was
$3.6 million , or$0.08 per diluted share, compared with$1.4 million , or$0.03 per diluted share, for the comparable quarter last year. GAAP to non-GAAP adjustments for income exclude costs related to the relocation, expenses related to the grand opening of theSmith & Wesson Academy , and a gain on sale of certain real estate. For a detailed reconciliation, see the schedules that follow in this release.Non-GAAP Adjusted EBITDAS was
$16.8 million , or 12.4% of net sales, compared with$13.9 million , or 12.0% of net sales, for the comparable quarter last year.
Conference Call and Webcast
The company will host a conference call and webcast on
Reconciliation of
In this press release, certain non-GAAP financial measures, including "non-GAAP net sales," "non-GAAP gross profit," "non-GAAP gross margin," "non-GAAP operating expenses," "non-GAAP operating income," "non-GAAP net income," "Non-GAAP net income per share – diluted," "Adjusted EBITDAS," "Adjusted EBITDAS Margin," and "free cash flow" are presented. We use these non-GAAP financial measures to facilitate a comparison of our operating performance on a consistent basis from period to period that, when viewed in combination with our results prepared in accordance with GAAP, provides a more complete understanding of factors and trends affecting our business than does GAAP measures alone. We believe these financial measures assist our board of directors, management, investors, and other users of the financial statements in comparing our results on a consistent basis from period to period because it removes certain non-cash items and other items that we do not consider to be indicative of our core and/or ongoing operations. We believe it is useful for us and the reader to review, as applicable, both (1) GAAP measures that include (i) interest expense, (ii) income tax expense, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) an accrued legal settlement, (vi)
About
Safe Harbor Statement
Certain statements contained in this press release may be deemed to be forward-looking statements under federal securities laws, and we intend that such forward-looking statements be subject to the safe-harbor created thereby. Such forward-looking statements include, among others, that (i) our momentum is strong and building, our brand and product assortment are driving continued healthy profitability, and we remain confident in the direction and trajectory of our business against the backdrop of a healthy and stable market; (ii) we are now turning our focus to increasing production to meet market demand, which should continue to have a positive impact on margins; (iii) we believe the strength of our brand, product assortment, and new product offerings are helping us drive growth and take share in an otherwise stable market; and (iv) we expect our fourth quarter sales will be up 10-12% over fiscal 2025 fourth quarter sales. We caution that these statements are qualified by important risks, uncertainties, and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, economic, social, political, legislative, and regulatory factors; the impact of tariffs; the potential for increased regulation of firearms and firearm-related products; actions of social activists that could have an adverse effect on our business; the impact of lawsuits; the demand for our products; the state of the
Contact:
investorrelations@smith-wesson.com
(413) 747-3448
| CONSOLIDATED BALANCE SHEETS | ||||||||
| (Unaudited) | ||||||||
| As of: | ||||||||
| (In thousands, except par value and share data) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 18,421 | $ | 25,231 | ||||
| Marketable securities | 5,041 | — | ||||||
| Accounts receivable, net of allowances for credit losses of | 50,834 | 55,868 | ||||||
| Inventories | 175,264 | 189,840 | ||||||
| Prepaid expenses and other current assets | 7,702 | 6,260 | ||||||
| Income tax receivable | 4,271 | 66 | ||||||
| Total current assets | 261,533 | 277,265 | ||||||
| Property, plant, and equipment, net of accumulated depreciation and amortization of | 238,578 | 242,648 | ||||||
| Intangibles, net | 2,195 | 2,409 | ||||||
| 19,024 | 19,024 | |||||||
| Deferred income taxes | 9,584 | 10,260 | ||||||
| Other assets | 7,090 | 8,006 | ||||||
| Total assets | $ | 538,004 | $ | 559,612 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 25,494 | $ | 26,887 | ||||
| Accrued expenses and deferred revenue | 18,770 | 24,678 | ||||||
| Accrued payroll and incentives | 11,246 | 9,060 | ||||||
| Accrued profit sharing | 1,389 | 4,636 | ||||||
| Accrued warranty | 1,244 | 1,379 | ||||||
| Total current liabilities | 58,143 | 66,640 | ||||||
| Notes and loans payable | 74,056 | 79,096 | ||||||
| Finance lease payable, net of current portion | 32,644 | 33,703 | ||||||
| Other non-current liabilities | 9,743 | 7,719 | ||||||
| Total liabilities | 174,586 | 187,158 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders' equity: | ||||||||
| Preferred stock, issued or outstanding | — | — | ||||||
| Common stock, 44,493,745 shares issued and outstanding on 2026 and 75,789,455 shares issued and 44,111,461 shares outstanding on | 44 | 76 | ||||||
| Additional paid-in capital | — | 298,075 | ||||||
| Retained earnings | 363,374 | 532,615 | ||||||
| — | (458,312) | |||||||
| Total stockholders' equity | 363,418 | 372,454 | ||||||
| Total liabilities and stockholders' equity | $ | 538,004 | $ | 559,612 | ||||
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||||
| (Unaudited) | ||||||||||||||||||
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||||
| (In thousands, except per share data) | ||||||||||||||||||
| Net sales | $ | 135,709 | $ | 115,885 | $ | 345,457 | $ | 333,899 | ||||||||||
| Cost of sales | 100,120 | 87,938 | 257,444 | 247,261 | ||||||||||||||
| Gross profit | 35,589 | 27,947 | 88,013 | 86,638 | ||||||||||||||
| Operating expenses: | ||||||||||||||||||
| Research and development | 2,412 | 2,869 | 7,852 | 7,605 | ||||||||||||||
| Selling, marketing, and distribution | 11,170 | 10,336 | 30,259 | 29,839 | ||||||||||||||
| General and administrative | 15,482 | 12,379 | 42,263 | 40,959 | ||||||||||||||
| Gain on sale/disposition of assets, net | (188) | (2,382) | (231) | (2,521) | ||||||||||||||
| Total operating expenses | 28,876 | 23,202 | 80,143 | 75,882 | ||||||||||||||
| Operating income | 6,713 | 4,745 | 7,870 | 10,756 | ||||||||||||||
| Other expense, net: | ||||||||||||||||||
| Other income/(expense), net | 185 | — | 523 | (11) | ||||||||||||||
| Interest expense, net | (1,527) | (1,723) | (4,117) | (3,875) | ||||||||||||||
| Total other expense, net | (1,342) | (1,723) | (3,594) | (3,886) | ||||||||||||||
| Income before income taxes | 5,371 | 3,022 | 4,276 | 6,870 | ||||||||||||||
| Income tax expense | 1,618 | 920 | 2,017 | 2,078 | ||||||||||||||
| Net income | $ | 3,753 | $ | 2,102 | $ | 2,259 | $ | 4,792 | ||||||||||
| Net income per share: | ||||||||||||||||||
| Basic - net income | $ | 0.08 | $ | 0.05 | $ | 0.05 | $ | 0.11 | ||||||||||
| Diluted - net income | $ | 0.08 | $ | 0.05 | $ | 0.05 | $ | 0.11 | ||||||||||
| Weighted average number of common shares outstanding: | ||||||||||||||||||
| Basic | 44,493 | 44,038 | 44,384 | 44,627 | ||||||||||||||
| Diluted | 44,982 | 44,398 | 44,825 | 45,069 | ||||||||||||||
| CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||
| (Unaudited) | |||||||||
| For the Nine Months Ended | |||||||||
| 2026 | 2025 | ||||||||
| (In thousands) | |||||||||
| Cash flows from operating activities: | |||||||||
| Net income | $ | 2,259 | $ | 4,792 | |||||
| Adjustments to reconcile net income to net cash provided by/(used in) operating activities: | |||||||||
| Depreciation and amortization | 23,706 | 23,860 | |||||||
| Gain on sale/disposition of assets | (231) | (2,521) | |||||||
| Deferred income taxes | 676 | (63) | |||||||
| Stock-based compensation expense | 6,364 | 5,724 | |||||||
| Non-cash sublease income | (1,341) | (1,287) | |||||||
| Unrealized gain on marketable securities | (407) | — | |||||||
| Changes in operating assets and liabilities: | |||||||||
| Accounts receivable | 5,034 | 1,629 | |||||||
| Inventories | 14,576 | (38,439) | |||||||
| Prepaid expenses and other current assets | (1,442) | (3,015) | |||||||
| Income taxes | (4,205) | (4,713) | |||||||
| Accounts payable | (893) | (16,750) | |||||||
| Accrued payroll and incentives | 2,186 | (8,160) | |||||||
| Accrued profit sharing | (3,247) | (7,201) | |||||||
| Accrued expenses and deferred revenue | (3,268) | (2,244) | |||||||
| Accrued warranty | (135) | (377) | |||||||
| Other assets | 105 | 946 | |||||||
| Other non-current liabilities | (123) | (232) | |||||||
| Net cash provided by/(used in) operating activities | 39,614 | (48,051) | |||||||
| Cash flows from investing activities: | |||||||||
| Purchases of marketable securities | (4,634) | — | |||||||
| Payments to acquire patents and software | (62) | (150) | |||||||
| Proceeds from sale of property and equipment | 136 | 2,668 | |||||||
| Payments to acquire property and equipment | (18,914) | (14,314) | |||||||
| Net cash used in investing activities | (23,474) | (11,796) | |||||||
| Cash flows from financing activities: | |||||||||
| Proceeds from loans and notes payable | 25,000 | 70,000 | |||||||
| Payments on notes and loans payable | (30,000) | — | |||||||
| Cash paid for debt issuance costs | (219) | (941) | |||||||
| Payments on finance lease obligation | (144) | (134) | |||||||
| Payments to acquire treasury stock | — | (25,468) | |||||||
| Dividend distribution | (17,444) | (17,375) | |||||||
| Proceeds to acquire common stock from employee stock purchase plan | 743 | 749 | |||||||
| Payment of employee withholding tax related to restricted stock units | (886) | (1,119) | |||||||
| Net cash (used in)/provided by financing activities | (22,950) | 25,712 | |||||||
| Net decrease in cash and cash equivalents | (6,810) | (34,135) | |||||||
| Cash and cash equivalents, beginning of period | 25,231 | 60,839 | |||||||
| Cash and cash equivalents, end of period | $ | 18,421 | $ | 26,704 | |||||
| Supplemental disclosure of cash flow information | |||||||||
| Cash paid for: | |||||||||
| Interest, net of amounts capitalized | $ | 4,464 | $ | 4,219 | |||||
| Income taxes | $ | 3,743 | $ | 7,098 | |||||
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES (Dollars in thousands, except per share data) (Unaudited) | |||||||||||||||||||||||
| For the Three Months Ended | For the Nine Months Ended | ||||||||||||||||||||||
| $ | % of Sales | $ | % of Sales | $ | % of Sales | $ | % of Sales | ||||||||||||||||
| GAAP net sales | $ | 135,709 | $ | 115,885 | $ | 345,457 | $ | 333,899 | |||||||||||||||
| Relocation | — | (203) | — | (4,416) | |||||||||||||||||||
| Non-GAAP net sales | $ | 135,709 | $ | 115,682 | $ | 345,457 | $ | 329,483 | |||||||||||||||
| GAAP gross profit | $ | 35,589 | 26.2% | $ | 27,947 | 24.1% | $ | 88,013 | 25.5% | $ | 86,638 | 25.9% | |||||||||||
| Relocation expenses | (129) | 1,096 | (133) | 2,830 | |||||||||||||||||||
| Settlement | — | — | — | 70 | |||||||||||||||||||
| Non-GAAP gross profit | $ | 35,460 | 26.1% | $ | 29,043 | 25.1% | $ | 87,880 | 25.4% | $ | 89,538 | 27.2% | |||||||||||
| GAAP operating expenses | $ | 28,876 | 21.3% | $ | 23,202 | 20.0% | $ | 80,143 | 23.2% | $ | 75,882 | 22.7% | |||||||||||
| Relocation expenses | 10 | (149) | 372 | (586) | |||||||||||||||||||
| 34 | — | (452) | — | ||||||||||||||||||||
| Gain on sale of asset | — | 2,257 | — | 2,257 | |||||||||||||||||||
| Non-GAAP operating expenses | $ | 28,920 | 21.3% | $ | 25,310 | 21.9% | $ | 80,063 | 23.2% | $ | 77,553 | 23.5% | |||||||||||
| GAAP operating income | $ | 6,713 | 4.9% | $ | 4,745 | 4.1% | $ | 7,870 | 2.3% | $ | 10,756 | 3.2% | |||||||||||
| Settlement | — | — | — | 70 | |||||||||||||||||||
| Relocation expenses | (139) | 1,245 | (505) | 3,416 | |||||||||||||||||||
| (34) | — | 452 | — | ||||||||||||||||||||
| Gain on sale of asset | — | (2,257) | — | (2,257) | |||||||||||||||||||
| Non-GAAP operating income | $ | 6,540 | 4.8% | $ | 3,733 | 3.2% | $ | 7,817 | 2.3% | $ | 11,985 | 3.6% | |||||||||||
| GAAP net income | $ | 3,753 | 2.8% | $ | 2,102 | 1.8% | $ | 2,259 | 0.7% | $ | 4,792 | 1.4% | |||||||||||
| Settlement | — | — | — | 70 | |||||||||||||||||||
| Relocation expenses | (139) | 1,245 | (505) | 3,416 | |||||||||||||||||||
| (34) | — | 452 | — | ||||||||||||||||||||
| Gain on sale of asset | — | (2,257) | — | (2,257) | |||||||||||||||||||
| Tax effect of non-GAAP adjustments | 50 | 311 | 15 | (381) | |||||||||||||||||||
| Non-GAAP net income | $ | 3,630 | 2.7% | $ | 1,401 | 1.2% | $ | 2,221 | 0.6% | $ | 5,640 | 1.7% | |||||||||||
| GAAP net income per share - diluted | $ | 0.08 | $ | 0.05 | $ | 0.05 | $ | 0.11 | |||||||||||||||
| Settlement | — | — | — | — | |||||||||||||||||||
| Relocation expenses | — | 0.03 | (0.01) | 0.08 | |||||||||||||||||||
| — | — | 0.01 | — | ||||||||||||||||||||
| Gain on sale of asset | — | (0.05) | — | (0.05) | |||||||||||||||||||
| Tax effect of non-GAAP adjustments | — | 0.01 | — | (0.01) | |||||||||||||||||||
| Non-GAAP net income per share - diluted | $ | 0.08 | $ | 0.03 | (a) | $ | 0.05 | $ | 0.13 | ||||||||||||||
(a) Non-GAAP net income per share does not foot due to rounding.
| RECONCILIATION OF GAAP NET INCOME TO NON-GAAP ADJUSTED EBITDAS (In thousands) (Unaudited) | |||||||||||||||||
| For the Three Months Ended | For the Nine Months Ended | ||||||||||||||||
| GAAP net income | $ | 3,753 | $ | 2,102 | $ | 2,259 | $ | 4,792 | |||||||||
| Interest expense | 2,081 | 2,355 | 5,900 | 5,881 | |||||||||||||
| Income tax expense | 1,618 | 920 | 2,017 | 2,079 | |||||||||||||
| Depreciation and amortization | 7,177 | 7,548 | 23,527 | 23,754 | |||||||||||||
| Stock-based compensation expense | 2,374 | 2,002 | 6,364 | 5,724 | |||||||||||||
| (34) | — | 452 | — | ||||||||||||||
| Gain on sale of asset | — | # | (2,257) | # | — | # | (2,257) | ||||||||||
| Settlement | — | — | — | 70 | |||||||||||||
| Relocation expense | (139) | 1,230 | (505) | 3,143 | |||||||||||||
| Non-GAAP Adjusted EBITDAS | $ | 16,830 | $ | 13,900 | $ | 40,014 | $ | 43,186 | |||||||||
| Non-GAAP Adjusted EBITDAS Margin | 12.4% | 12.0% | 11.6% | 13.1% | |||||||||||||
| RECONCILIATION OF (In thousands) (Unaudited) | ||||||||||||||||
| For the Three Months Ended | For the Nine Months Ended | |||||||||||||||
| Net cash provided by/(used in) operating activities | $ | 20,456 | (9,839) | $ | 39,614 | $ | (48,051) | |||||||||
| Payments to acquire property and equipment | (3,633) | (6,310) | (18,914) | (14,314) | ||||||||||||
| Free cash flow | $ | 16,823 | $ | (16,149) | $ | 20,700 | $ | (62,365) | ||||||||

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/286362
SOURCE